We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+19.44%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.38B
AUM Growth
-$27.3M
Cap. Flow
-$219M
Cap. Flow %
-9.21%
Top 10 Hldgs %
39.28%
Holding
114
New
41
Increased
19
Reduced
15
Closed
25

Top Buys

Rank Stock Value
1
BHVN icon
Biohaven
BHVN
+$53.5M
2
T icon
AT&T
T
+$52.8M
3
NKE icon
Nike
NKE
+$50.1M
4
WYNN icon
Wynn Resorts
WYNN
+$50.1M
5
FIS icon
Fidelity National Information Services
FIS
+$49.2M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$89.1M
2
DIS icon
Walt Disney
DIS
+$87.4M
3
AMZN icon
Amazon
AMZN
+$82.9M
4
IQV icon
IQVIA
IQV
+$71.9M
5
GPN icon
Global Payments
GPN
+$71.2M

Sector Composition

Rank Sector Weight
1 Healthcare 46.26%
2 Consumer Discretionary 16.29%
3 Industrials 12.13%
4 Consumer Staples 8.08%
5 Technology 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
101
Microsoft
MSFT
$3.71T
– –
-382,380
Closed -$89.1M
NOW icon
102
ServiceNow
NOW
$129B
– –
-770,750
Closed -$58.2M
NUVL
103
DELISTED
Nuvalent
NUVL
– –
-101,003
Closed -$1.96M
PHVS icon
104
Pharvaris
PHVS
$2.44B
– –
-746,965
Closed -$5.73M
SLDB icon
105
Solid Biosciences
SLDB
$900M
– –
-40,000
Closed -$4.2M
THRD
106
DELISTED
Third Harmonic Bio
THRD
– –
-200,000
Closed -$3.79M
TMUS icon
107
T-Mobile US
TMUS
$190B
– –
-369,828
Closed -$49.6M
TTWO icon
108
Take-Two Interactive
TTWO
$46.1B
– –
-536,170
Closed -$58.4M
V icon
109
Visa
V
$677B
– –
-271,968
Closed -$48.3M
AMAM
110
DELISTED
Ambrx Biopharma Inc
AMAM
– –
-1,491,832
Closed -$1.61M
SIOX
111
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-5,914,000
Closed -$1.66M
OTIC
112
DELISTED
Otonomy, Inc.
OTIC
– –
-3,144,196
Closed -$928K
FLAC
113
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
– –
-87,498
Closed -$872K
TMPMW
114
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
– –
-52,775
Closed -$1K
1 2 3 4
5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Suvretta Capital Management held 114 positions worth $2.38B, down 1.1% from $2.41B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Suvretta Capital Management withdrew a net $219M in Q4 2022, closing 25 positions and reducing 15 holdings. Its most notable exit was Microsoft, an estimated $89.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 45% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Suvretta Capital Management opened a new position in AT&T worth $54.3M.

  • Suvretta Capital Management's largest Q4 2022 buy was AT&T: 2,951,900 shares worth $54.3M.
  • Suvretta Capital Management added most to Biohaven in Q4 2022, an estimated $53.5M increase.
  • Suvretta Capital Management's biggest Q4 2022 reduction was IQVIA, cutting an estimated $71.9M.
  • Suvretta Capital Management fully exited Microsoft in Q4 2022, selling an estimated $89.1M.
  • Suvretta Capital Management's ten largest holdings make up 39% of its $2.38B portfolio in Q4 2022.
  • Suvretta Capital Management opened 41 new positions and closed 25 in Q4 2022.
  • Suvretta Capital Management's portfolio value fell 1.1% quarter-over-quarter to $2.38B.

Based on Suvretta Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.